Convergence for Translation: Drug-Delivery Research in Multidisciplinary Teams.

The void between drug discovery and successful translation to humans is vast. In order to develop effective solutions, convergence of a multidisciplinary team with a range of expertise is required. In this Essay, examples of successful sustained delivery systems for antimalarials and antiretrovirals, as well as to the gastrointestinal tract are discussed.

[1]  Robert Langer,et al.  Miniaturized neural system for chronic, local intracerebral drug delivery , 2018, Science Translational Medicine.

[2]  Nima Hamidi,et al.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.

[3]  D. Podzamczer,et al.  Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial , 2017, The Lancet.

[4]  Robert Langer,et al.  Fabrication of fillable microparticles and other complex 3D microstructures , 2017, Science.

[5]  Robert Langer,et al.  Triggerable tough hydrogels for gastric resident dosage forms , 2017, Nature Communications.

[6]  Robert Langer,et al.  Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice. , 2017, Gastroenterology.

[7]  Hannah C. Slater,et al.  Oral, ultra–long-lasting drug delivery: Application toward malaria elimination goals , 2016, Science Translational Medicine.

[8]  Ameya R. Kirtane,et al.  Past, Present, and Future Drug Delivery Systems for Antiretrovirals. , 2016, Journal of pharmaceutical sciences.

[9]  Giovanni Traverso,et al.  Low-frequency ultrasound for drug delivery in the gastrointestinal tract , 2016, Expert opinion on drug delivery.

[10]  Mtn -Aspire Study Team.  Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women , 2016 .

[11]  Daniel G. Anderson,et al.  Ultrasound-mediated gastrointestinal drug delivery , 2015, Science Translational Medicine.

[12]  H. Kishimoto,et al.  Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA , 2015, Archives of Osteoporosis.

[13]  G. Dennis Shanks,et al.  Supplemental Appendix A: 240 Studies Assessed for Inclusion Two-year Evaluation of Intermittent Preventive Treatment for Children (iptc) Combined with Timely Home Treatment for Malaria Control In , 2022 .

[14]  L. Dalgaard.  Comparison of minipig, dog, monkey and human drug metabolism and disposition. , 2015, Journal of pharmacological and toxicological methods.

[15]  Jaline Gerardin,et al.  Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination , 2015, BMC Infectious Diseases.

[16]  James Y. Dai,et al.  Tenofovir-based preexposure prophylaxis for HIV infection among African women. , 2015, The New England journal of medicine.

[17]  M. Saag.  Preventing HIV in women--still trying to find their VOICE. , 2015, The New England journal of medicine.

[18]  Teun Bousema,et al.  Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Teun Bousema,et al.  The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study. , 2014, The Journal of infectious diseases.

[20]  Samir Mitragotri,et al.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.

[21]  A. Weintrob,et al.  Compliance with antimalarial chemoprophylaxis recommendations for wounded United States military personnel admitted to a military treatment facility. , 2014, The American journal of tropical medicine and hygiene.

[22]  Victor A Alegana,et al.  The changing risk of Plasmodium falciparum malaria infection in Africa: 2000–10: a spatial and temporal analysis of transmission intensity , 2014, The Lancet.

[23]  R. Langer.  Biomaterials and biotechnology: from the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering. , 2013, Journal of biomedical materials research. Part A.

[24]  P. Eckhoff,et al.  Mathematical Models of Within-Host and Transmission Dynamics to Determine Effects of Malaria Interventions in a Variety of Transmission Settings , 2013, The American journal of tropical medicine and hygiene.

[25]  K. Lohr,et al.  Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States , 2012, Annals of Internal Medicine.

[26]  W. Busse,et al.  Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). , 2012, The Journal of allergy and clinical immunology.

[27]  Laura M Ensign,et al.  Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. , 2012, Advanced drug delivery reviews.

[28]  Phillip A Sharp,et al.  Promoting Convergence in Biomedical Science , 2011, Science.

[29]  Christopher D. Clagett,et al.  An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia. , 2010, The American journal of tropical medicine and hygiene.

[30]  Barry S. Coller,et al.  Traversing the Valley of Death: A Guide to Assessing Prospects for Translational Success , 2009, Science Translational Medicine.

[31]  N. Peppas,et al.  Molecular Aspects of Mucoadhesive Carrier Development for Drug Delivery and Improved Absorption , 2009, Journal of biomaterials science. Polymer edition.

[32]  C. Porter,et al.  Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. , 2008, Gastroenterology.

[33]  Robert Langer,et al.  Transdermal drug delivery , 2008, Nature Biotechnology.

[34]  V. Cowles,et al.  Case studies in swelling polymeric gastric retentive tablets , 2006, Expert opinion on drug delivery.

[35]  Abraham J Domb,et al.  Polyanhydrides: an overview. , 2002, Advanced drug delivery reviews.

[36]  S. Mitragotri,et al.  Ultrasound-mediated transdermal protein delivery , 1995, Science.

[37]  T. Kararli.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.